N-(1-{5-[(propan-2-yloxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332116319 (In-Stock Building Blocks)
- IUPAC Name
- N-(1-{5-[(propan-2-yloxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)ethene-1-sulfonamide
- Mol formula
- C10H17N3O4S
- Mol weight
- 275 Da
- Catalog Number(s)
- BBLS21332116319, EN300-54824950, bbls21332116319
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.86
- Heavy atoms count
- 18
- Rotatable bond count
- 6
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.6
- Polar surface area (Å)
- 94
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 1
![Chemical structure of N-(1-{5-[(propan-2-yloxy)methyl]-1,2,4-oxadiazol-3-yl}ethyl)ethene-1-sulfonamide (C10H17N3O4S) - CSSB21332116319](/st/structure/200/c06015a48f9f6c0639f6d9d821a9ca57/CC%2528C%2529OCC1%253DNC%2528%253DNO1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png "C10H17N3O4S")
- Zoom the structure
- CSSB21332116319
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 804.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 842.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 880.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 919.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 956.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,874.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,774.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,114.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-{1-[5-(ethoxymethyl)-1,2,4-oxadiazol-3-yl]ethyl}ethene-1-sulfonamide - CSSB06835390633](/st/structure/200/ef038f31b646fbce702ce32cd4f53256/CCOCc1nc%2528no1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[1-(5-ethyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB07105605001](/st/structure/200/9612f9fc7cd50a26180cc715148973ae/CCc1nc%2528no1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[1-(5-propyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB14902456111](/st/structure/200/23af3ad9555cbad7d8f00a6e84c5005f/CCCc1nc%2528no1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[(1R)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB20481155834](/st/structure/200/3715b138ee4d33f22d58afdfeb4b865c/C%255BC%2540%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528C%2529%253DN1.png)
![Chemical structure of N-[1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB09888515099](/st/structure/200/5e63667116f1e02b21db09b9e6d41a7f/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529c1noc%2528C%2529n1.png)
![Chemical structure of N-[(1S)-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB20481151831](/st/structure/200/8fdb5c3bed4e7d3284fc898728f62379/C%255BC%2540H%255D%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528C%2529%253DN1.png)
![Chemical structure of N-[1-(5-benzyl-1,2,4-oxadiazol-3-yl)ethyl]ethene-1-sulfonamide - CSSB21332082711](/st/structure/200/f88dfbef03a09cc1257993888b245742/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNOC%2528CC2%253DCC%253DCC%253DC2%2529%253DN1.png)
